Expertise in
17
conditions

Dr. Scott E. Eggener

Urology
University Of Chicago Medical Center
5841 S Maryland Ave, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
Expertise in
17
conditions
University Of Chicago Medical Center
5841 S Maryland Ave, 
Chicago, IL 

Overview

Scott Eggener is a Urologist practicing medicine in Chicago, Illinois.

Dr. Eggener is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Prostatectomy, and Nephrectomy.

He is actively involved in clinical research, co-authoring 280 peer reviewed articles and participating in 7 clinical trials. Dr. Eggener is currently accepting new patients.

Specialties

Urology

Licenses

Urology in CA

Hospital Affiliations

Ronald Reagan UCLA Medical Center
Ingalls Memorial Hospital
The University Of Chicago Medical Center
Uchicago Medicine Northwest Indiana

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

University of Chicago Medical Center
5841 S Maryland Ave, Chicago, IL 60637

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 24, 2026
Intervention Type: Drug, Procedure, Other
Study Drugs: Antiandrogen therapy, Docetaxel
Study Phase: Phase 2
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2026
Intervention Type: Procedure, Other
Study Phase: Not Applicable
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: March 12, 2026
Intervention Type: Procedure, Other
A Randomized Controlled Trial Of AdV-tk + Valacyclovir Administered During Active Surveillance For Newly Diagnosed Prostate Cancer
A Randomized Controlled Trial Of AdV-tk + Valacyclovir Administered During Active Surveillance For Newly Diagnosed Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Biological, Drug
Study Drugs: Aglatimagene Besadenovec, Valacyclovir
Study Phase: Phase 2
Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial Nephrectomy
Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial Nephrectomy
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
Enrollment Status: Completed
Publish Date: August 09, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 2/Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Drug, Diagnostic test
Study Phase: Phase 3
View 6 Less Clinical Trials

280 Total Publications

Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.
Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.
Journal: Annals of internal medicine
Published: June 22, 2026
Similar Doctors
Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
 (7.4 miles away)
312-695-8146
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amy Krambeck is a Urologist practicing medicine in Chicago, Illinois. Dr. Krambeck is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Enlarged Prostate (BPH), Kidney Stones, Bladder Stones, Ureteroscopy, and Lithotripsy. Dr. Krambeck is board certified in American Board Of Urology - Urology (Certified). Dr. Krambeck is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (0.1 miles away)
773-702-3080
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Steinberg is a Urologist practicing medicine in Chicago, Illinois. Dr. Steinberg is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Ureteral Reconstruction. Dr. Steinberg is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required
Before you request
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
 (7.4 miles away)
312-695-8146
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Brannigan is a Urologist practicing medicine in Chicago, Illinois. Dr. Brannigan is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Low Testosterone, Infertility, Testicular Failure, Vasectomy, and Orchiectomy. Dr. Brannigan is board certified in American Board Of Urology - Urology (Certified). Dr. Brannigan is currently accepting new patients.

Frequently Asked Questions about Dr. Scott E. Eggener

How do I make an appointment with Dr. Scott E. Eggener?

You can book an appointment with Dr. Scott E. Eggener by calling their office at 773-702-1860. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Scott E. Eggener a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott E. Eggener is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Scott E. Eggener specialize in?

While Dr. Scott E. Eggener is a Urology, they have specific expertise in Prostate Cancer, Testicular Cancer, and Prostatectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Scott E. Eggener participate in research or clinical trials?

Yes. Dr. Scott E. Eggener has published 280 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Scott E. Eggener's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Scott E. Eggener accept my insurance?

Dr. Scott E. Eggener accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 773-702-1860 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Eggener's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile